Valid for Submission
H59.349 is a billable diagnosis code used to specify a medical diagnosis of postprocedural hematoma of unspecified eye and adnexa following other procedure. The code H59.349 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
Unspecified diagnosis codes like H59.349 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|919||COMPLICATIONS OF TREATMENT WITH MCC||21||1.8344|
|920||COMPLICATIONS OF TREATMENT WITH CC||21||1.0273|
|921||COMPLICATIONS OF TREATMENT WITHOUT CC/MCC||21||0.6914|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
H59349 replaces the following previously assigned ICD-10 code(s):
Convert H59.349 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code H59.349 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.